MODIFIED GLP-1 RECEPTOR AGONISTS AND THEIR PHARMACOLOGICAL METHODS OF USE - Patent 1539210

(19)

(11)

EP 1 539 210 A2

(12)

(88)	Date of publication A3:
	23.12.2004

(43)	Date of publication:
	15.06.2005 Bulletin 2005/24

(21)	Application number: 03755799.8

(22)	Date of filing: 04.09.2003

(51)	International Patent Classification (IPC)⁷: A61K 38/00

(86)	International application number:
	PCT/US2003/028093

(87)	International publication number:
	WO 2004/022004 (18.03.2004 Gazette 2004/12)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
	Designated Extension States:
	AL LT LV MK

(30)

Priority:

06.09.2002 US 408696 P
09.01.2003 US 439369 P

(71)	Applicant: Bayer Pharmaceuticals Corporation
	West Haven, CT 06516 (US)

(72)	Inventors:
	PAN, Clark Castro Valley, CA 94552 (US) WHELAN, James, P. Madison, CT 06443 (US)

(74)	Representative: Burkert, Frank, Dr.
	Bayer HealthCare AGCAO Law and PatentsPatents and Licensing 51368 Leverkusen 51368 Leverkusen (DE)

(54)	MODIFIED GLP-1 RECEPTOR AGONISTS AND THEIR PHARMACOLOGICAL METHODS OF USE